排序方式:
    總頁 2 
      Go

    1.Upgrade of chrysomycin A as a novel topoisomerase II inhibitor to curb KRAS-mutant lung adenocarcinoma progression

    Zhang, JM, Liu, P, C     More...

    PHARMACOLOGICAL RESEARCH[1043-6618], Published 2023, Volume 187,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  9.1  发表年影響因子:  9.1 

    2.CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer

    Wang, J, Li, RZ, Wan     More...

    PHARMACOLOGICAL RESEARCH[1043-6618], Published 2023, Volume 194,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  9.1  发表年影響因子:  9.1 

    3.Traditional Patchouli essential oil modulates the host's immune responses and gut microbiota and exhibits potent anti-cancer effects in Apc(Min /+) mice

    Leong, W, Huang, GX,     More...

    PHARMACOLOGICAL RESEARCH[1043-6618], Published 2022, Volume 176,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 25  2023影響因子:  9.1  发表年影響因子:  9.3 

    4.Elucidation of the anti-inflammatory mechanism of Er Miao San by integrative approach of network pharmacology and experimental verification

    Guo, Bin, Zhao, CaiP     More...

    Pharmacological Research[1043-6618], Published 2022, Volume 175,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 65  2023影響因子:  9.1  发表年影響因子:  9.3 

    5.IKK beta increases neuropilin-2 and promotes the inhibitory function of CD9(+) Bregs to control allergic diseases

    Wang, YY, Deng, WD,     More...

    PHARMACOLOGICAL RESEARCH[1043-6618], Published 2022, Volume 185,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2023影響因子:  9.1  发表年影響因子:  9.3 

    6.Macrophage 3D migration: A potential therapeutic target for inflammation and deleterious progression in diseases

    GAO, WanJiao, LIU, M     More...

    Pharmacological Research[1043-6618], Published 2021, Volume 167,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 25  2023影響因子:  9.1  发表年影響因子:  10.334 

    7.Suppression of macrophage migration by down-regulating Src/FAK/P130Cas activation contributed to the anti-inflammatory activity of sinomenine

    Gao, WanJiao, Xie, Y     More...

    Pharmacological Research[1043-6618], Published 2021, Volume 167,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 28  2023影響因子:  9.1  发表年影響因子:  10.334 

    8.Icariin enhances youth-like features by attenuating the declined gut microbiota in the aged mice

    Li, Xiaoang, Khan, I     More...

    Pharmacological Research[1043-6618], Published 2021, Volume 168,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 27  2023影響因子:  9.1  发表年影響因子:  10.334 

    9.Saponins isolated from Radix polygalae extent lifespan by modulating complement C3 and gut microbiota

    Zeng, W, Wu, AG, Zho     More...

    PHARMACOLOGICAL RESEARCH[1043-6618], Published 2021, Volume 170,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 18  2023影響因子:  9.1  发表年影響因子:  10.334 

    10.Potential therapeutic compounds from traditional Chinese medicine targeting endoplasmic reticulum stress to alleviate rheumatoid arthritis

    Dias, IRDR, Lo, HH,     More...

    PHARMACOLOGICAL RESEARCH[1043-6618], Published 2021, Volume 170,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 27  2023影響因子:  9.1  发表年影響因子:  10.334 

    11.Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling

    Li, JX, Li, RZ, Sun,     More...

    PHARMACOLOGICAL RESEARCH[1043-6618], Published 2021, Volume 171,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 37  2023影響因子:  9.1  发表年影響因子:  10.334 

    12.Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry

    Zhang, DQ, Hamdoun,     More...

    PHARMACOLOGICAL RESEARCH[1043-6618], Published 2021, Volume 172,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 49  2023影響因子:  9.1  发表年影響因子:  10.334 

    13.SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells

    Xu, SuWei, Law, Bett     More...

    Pharmacological Research[1043-6618], Published 2020, Volume 153,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 33  2023影響因子:  9.1  发表年影響因子:  7.658 

    14.Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020

    Zheng, Y, Xiong, C,     More...

    PHARMACOLOGICAL RESEARCH[1043-6618], Published 2020, Volume 157,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 47  2023影響因子:  9.1  发表年影響因子:  7.658 

    15.ISO/TC 249 platform promotes the development of international standardization and trade for the Chinese medicines industry

    Huang, YuFeng, He, F     More...

    Pharmacological Research[1043-6618], Published 2020, Volume 160,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 11  2023影響因子:  9.1  发表年影響因子:  7.658 

    16.Network pharmacological approach for elucidating the mechanisms of traditional Chinese medicine in treating COVID-19 patients

    Pan, HuDan, Yao, Xia     More...

    Pharmacological Research[1043-6618], Published 2020, Volume 159,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 15  2023影響因子:  9.1  发表年影響因子:  7.658 

    17.Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway

    Xie, YaJia, Gao, Wei     More...

    Pharmacological Research[1043-6618], Published 2020, Volume 159,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 26  2023影響因子:  9.1  发表年影響因子:  7.658 

    18.The immunomodulatory role of PDEs inhibitors in immune cells: therapeutic implication in rheumatoid arthritis

    He, YuFei, Mai, ChuT     More...

    Pharmacological Research[1043-6618], Published 2020, Volume 161,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 13  2023影響因子:  9.1  发表年影響因子:  7.658 

    19.Current Policies and Measures on the Development of Traditional Chinese Medicine in China

    Wang, WanYing, Zhou,     More...

    Pharmacological Research[1043-6618], Published 2020, Volume 163,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 74  2023影響因子:  9.1  发表年影響因子:  7.658 

    20.Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling

    Zhang, Yueyang, Zou,     More...

    Pharmacological Research[1043-6618], Published 2019, Volume 142, Pages 140-150

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 32  2023影響因子:  9.1  发表年影響因子:  5.893 

    顯示      條  合計   34   條
      總頁 2 
        Go

      本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

      Copyright © 2018 澳門科技大學學者庫